Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.
The ability of cardiac stem cells (CSCs) to promote myocardial repair under clinically relevant conditions (i.e., when delivered intravascularly after reperfusion) is unknown. Thus, rats were subjected to a 90-min coronary occlusion; at 4 h after reperfusion, CSCs were delivered to the coronary arteries via a catheter positioned into the aortic root. Echocardiographic analysis showed that injection of CSCs attenuated the increase in left ventricular (LV) end-diastolic dimensions and impairment in LV systolic performance at 5 weeks after myocardial infarction. Pathologic analysis showed that treated hearts exhibited a smaller increase in LV chamber diameter and volume and a higher wall thickness-to-chamber radius ratio and LV mass-to-chamber volume ratio. CSCs induced myocardial regeneration, decreasing infarct size by 29%. A diploid DNA content and only two chromosomes 12 were found in new cardiomyocytes, indicating that cell fusion did not contribute to tissue reconstitution. In conclusion, intravascular injection of CSCs after reperfusion limits infarct size, attenuates LV remodeling, and ameliorates LV function. This study demonstrates that CSCs are effective when delivered in a clinically relevant manner, a clear prerequisite for clinical translation, and that these beneficial effects are independent of cell fusion. The results establish CSCs as candidates for cardiac regeneration and support an approach in which the heart's own stem cells could be collected, expanded, and stored for subsequent therapeutic repair.
Dawn
Buddhadeb
B
Institute of Molecular Cardiology, University of Louisville, Louisville, KY 40202, USA.
Stein
Adam B
AB
Urbanek
Konrad
K
Rota
Marcello
M
Whang
Brian
B
Rastaldo
Raffaella
R
Torella
Daniele
D
Tang
Xian-Liang
XL
Rezazadeh
Arash
A
Kajstura
Jan
J
Leri
Annarosa
A
Hunt
Greg
G
Varma
Jai
J
Prabhu
Sumanth D
SD
Anversa
Piero
P
Bolli
Roberto
R
D000818:Animals; D002459:Cell Fusion; D002465:Cell Movement; D004452:Echocardiography; D009203:Myocardial Infarction / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D009206:Myocardium / Q000473:pathology; D032383:Myocytes, Cardiac / Q000166:cytology / Q000502:physiology*; D051381:Rats; D011916:Rats, Inbred F344; D012038:Regeneration; D033581:Stem Cell Transplantation; D016277:Ventricular Function, Left
J Clin Invest. 1997 Oct 15;100(8):1991-9
9329962
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2088-93
12576546
Nature. 2001 Apr 5;410(6829):701-5
11287958
Circulation. 2001 Dec 11;104(24):2981-9
11739316
N Engl J Med. 2002 Jan 3;346(1):5-15
11777997
Nature. 2002 Jan 10;415(6868):240-3
11805849
Circulation. 2002 Oct 8;106(15):1913-8
12370212
Lancet. 2003 Jan 4;361(9351):45-6
12517467
Nature. 2003 Apr 24;422(6934):897-901
12665832
Nature. 2003 Apr 24;422(6934):901-4
12665833
Circulation. 2003 May 13;107(18):2294-302
12707230
N Engl J Med. 2003 Jul 17;349(3):267-74
12867611
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10440-5
12928492
Cell. 2003 Sep 19;114(6):763-76
14505575
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12313-8
14530411
Nature. 2003 Oct 30;425(6961):968-73
14555960
Circulation. 2003 Nov 4;108(18):2212-8
14557356
Nat Med. 2003 Dec;9(12):1528-32
14625543
Circ Res. 2004 Feb 6;94(2):132-4
14764646
Circ Res. 2004 Mar 5;94(4):514-24
14726476
J Biol Chem. 2004 Mar 19;279(12):11384-91
14702342
Circ Res. 2004 Jul 23;95(2):125-34
15271864
Circ Res. 2004 Oct 29;95(9):911-21
15472116
Circ Res. 1979 Apr;44(4):503-12
428047
Circ Res. 2004 Dec 10;95(12):1191-9
15550692
Lancet. 2003 Jan 4;361(9351):47-9
12517468
Circ Res. 2003 Feb 7;92(2):139-50
12574141
J Appl Physiol (1985). 1993 May;74(5):2598-605
8335596